Barclays PLC Portfolio Holdings

Barclays PLC

  • $436 Billion
  • Q2 2025

Barclays PLC has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $436 Billion distributed in 12350 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Microsoft Corp with a value of $17.4B, Nvidia Corp with a value of $15.9B, Apple Inc. with a value of $9.34B, Amazon Com Inc with a value of $7.98B, and Tesla, Inc. with a value of $6.51B.

Examining the 13F form we can see an increase of $184B in the current position value, from $252B to 436B.

Barclays PLC is based out at London, X0

Below you can find more details about Barclays PLC portfolio as well as his latest detailed transactions.

Portfolio value $436 Billion
ETFs: $158 Billion
Technology: $99.7 Billion
Consumer Cyclical: $34.9 Billion
Financial Services: $33.3 Billion
Communication Services: $27 Billion
Industrials: $20.8 Billion
Healthcare: $20 Billion
Consumer Defensive: $11.9 Billion
Other: $21.9 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$257M
$748,000 0.0% of portfolio
78,782
Q2 2025 Added 65.02%
$666M
$1.08 Million 0.0% of portfolio
37,681
Q2 2025 Added 62.39%
$827M
$1.74 Million 0.0% of portfolio
24,774
Q2 2025 Added 34.36%
Metsera Inc
-
$1.6 Million 0.0% of portfolio
-
Q2 2025 Added 182.03%
$908M
$1.82 Million 0.0% of portfolio
192,629
Q2 2025 Added 6.33%
$8.34B
$17.6 Million 0.0% of portfolio
631,989
Q2 2025 Reduced 21.42%
$532M
$1.14 Million 0.0% of portfolio
38,136
Q2 2025 Added 56.53%
Mgp Ingredients Inc New
-
$72,000 0.0% of portfolio
-
Q2 2025 Added 18.75%
Microbot Med Inc
-
$0 0.0% of portfolio
-
Q2 2025 Reduced 83.33%
Microchip Technology Inc.
-
$362,000 0.0% of portfolio
-
Q2 2025 Reduced 67.7%
Microstrategy Inc
-
$1.52 Million 0.0% of portfolio
-
Q2 2025 Reduced 57.41%
Microstrategy Inc
-
$242,000 0.0% of portfolio
-
Q2 2025 New
$1.83B
$1.24 Million 0.0% of portfolio
342,323
Q2 2025 Added 0.0%
$174M
$503,000 0.0% of portfolio
440,895
Q2 2025 Added 61.55%
$436M
$1.31 Million 0.0% of portfolio
46,393
Q2 2025 Added 43.5%
$6.64B
$20.3 Million 0.0% of portfolio
140,755
Q2 2025 Reduced 4.19%
Middlefield Banc Corp
-
$799,000 0.0% of portfolio
-
Q2 2025 Added 40.5%
$1.06B
$1.85 Million 0.0% of portfolio
34,049
Q2 2025 Added 47.88%
$363M
$1.25 Million 0.0% of portfolio
72,482
Q2 2025 Added 28.0%
$441M
$1.79 Million 0.0% of portfolio
62,378
Q2 2025 Added 49.29%
$30.3M
$0 0.0% of portfolio
1
Q2 2022 Reduced 100.0%
$472M
$1.35 Million 0.0% of portfolio
30,467
Q2 2025 Added 31.2%
$1.18B
$3.87 Million 0.0% of portfolio
199,294
Q2 2025 Added 131.34%
Millrose Pptys Inc
-
$1.13 Million 0.0% of portfolio
-
Q2 2025 Added 16.96%
$766M
$2.49 Million 0.0% of portfolio
407,721
Q2 2025 Added 86.04%
Mind Medicine Mindmed Inc
-
$1.14 Million 0.0% of portfolio
-
Q2 2025 Added 46.55%
$1.79B
$3.34 Million 0.0% of portfolio
60,597
Q2 2025 Added 45.15%
Mineralys Therapeutics Inc
-
$1.95 Million 0.0% of portfolio
-
Q2 2025 Added 337.34%
$6.77B
$708,000 0.0% of portfolio
38,837
Q2 2025 New
$4.99B
$8.86 Million 0.0% of portfolio
411,509
Q2 2025 Added 62.31%
$2.68B
$7.88 Million 0.0% of portfolio
154,871
Q2 2025 Added 90.48%
Mirum Pharmaceuticals Inc
-
$617,000 0.0% of portfolio
-
Q2 2025 New
$832M
$1.08 Million 0.0% of portfolio
92,299
Q2 2025 Added 60.92%
$1.72B
$1.34 Million 0.0% of portfolio
222,423
Q2 2025 Added 44.99%
$291M
$237,000 0.0% of portfolio
29,524
Q2 2025 Added 39.39%
$415M
$754,000 0.0% of portfolio
76,188
Q2 2025 Added 31.4%
$186B
$15,000 0.0% of portfolio
1,090
Q2 2025 Reduced 39.34%
Mks Inc.
-
$236,000 0.0% of portfolio
-
Q2 2025 New
Mobile Infrastructure Corp
-
$123,000 0.0% of portfolio
-
Q2 2025 Added 8,821.71%
$0
$3.09 Million 0.0% of portfolio
172,015
Q2 2025 Added 133.4%
$8.2B
$11.3 Million 0.0% of portfolio
114,945
Q2 2025 Added 50.23%
$108M
$237,000 0.0% of portfolio
16,869
Q2 2025 Added 123.88%
$2.39M
$0 0.0% of portfolio
14
Q2 2025 Reduced 99.89%
$3.92B
$10.2 Million 0.0% of portfolio
163,657
Q2 2025 Added 23.03%
$7.34B
$13.4 Million 0.0% of portfolio
127,383
Q2 2025 Reduced 6.66%
Momentus Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
$1.82B
$3.4 Million 0.0% of portfolio
39,302
Q2 2025 Added 32.88%
$8.7B
$10.9 Million 0.0% of portfolio
34,731
Q2 2025 Added 5.06%
Monopar Therapeutics Inc
-
$261,000 0.0% of portfolio
-
Q2 2025 Added 60,608.33%

Summary

  • Portfolio
  • No. of Stocks 12,350
  • Current Value $436 Billion
  • Prior Value $252 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR/A
  • Activity in Q2 2025
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email